Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. R. Gosker, F. M. E. Franssen, F. Ellens, P. R. Heuts, N. H. M. K. Lencer, E. M. F. Wouters, A. M. W. J. Schols (Maastricht, The Netherlands). Generalized muscle dysfunction in COPD and chronic heart failure independent of disease severity. Eur Respir J 2001; 16: Suppl. 31, 1315

Member's Comments

No comment yet.

Related content which might interest you: Hyperventilation, reduced muscle strength and pulmonary hypertension are the main determinants of chronic dyspnea in chronic heart failure patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 COPD prevalence in chronic heart failure Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020 Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 The effect of COPD on muscle structure and function Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles Year: 2006 Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 The effect of co-existent chronic heart failure (CHF) on lower limb muscle function in COPD: Propensity matched analysis Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 The prevalence of quadriceps weakness in COPD and the relationship with disease severity Source: Eur Respir J 2010; 36: 81-88 Year: 2010 Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting Year: 2010 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016